We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Rheumatology

Journal Scan / Research · November 23, 2021

Biologic Treatments in Takayasu's Arteritis

Scandinavian Journal of Rheumatology


Additional Info

Scandinavian Journal of Rheumatology
Biologic treatments in Takayasu's Arteritis: A comparative study of tumor necrosis factor inhibitors and tocilizumab
Scand J Rheumatol 2021 Oct 09;51(6)1224-1229, F Alibaz-Oner, S Kaymaz-Tahra, Ö Bayındır, A Yazici, B Ince, K Kalkan, NA Kanıtez, SB Kocaer, NS Yasar Bilge, A Omma, E Durak, C Ilgın, S Akar, T Kaşifoğlu, F Önen, H Emmungil, M İnanç, A Cefle, K Aksu, G Keser, H Direskeneli

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading